| Sign In to gain access to subscriptions and/or personal tools. |
Prevention of cryoprecipitation during cardiopulmonary bypass in a patient with HIV-HCV co-infectionsDivision of Immunology and Allergy, CHUV, 1011 Lausanne, Switzerland
Division of Cardiovascular Surgery, CHUV, 1011 Lausanne, Switzerland
Division of Immunology and Allergy, CHUV, 1011 Lausanne, Switzerland
Background: There are no guidelines for the management of patients with cryoglobulins during cardiopulmonary bypass (CPB) necessitating core hypothermia. Objective: To evaluate a simple, pragmatic protocol of in vitro temperature-dependent cryoprecipitation of serum in patients with cryoglobulinemia before elective cardiac surgery with CPB. Methods: A 44-year-old female patient was known for chronic hepatitis C and type III cryoglobulinemia. Elective surgery was planned for an aortic arch aneurysm. A differential serum cryoprecipitation profile was established in vitro prior to surgery. Results: Whereas, at temperatures
Perfusion, Vol. 21, No. 5,
263-265 (2006) |
|||
15°C, cryoglobulin levels were
0.112 g/L (normal value <0.05 g/L), at 20°C and above, the precipitate was